We are live on ! Find out more
PCM

Patient Capital Management Portfolio holdings

AUM $2.74B
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+43.59%
3 Year Est. Return
+124.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.59B
AUM Growth
+$92.6M
Cap. Flow
-$53.5M
Cap. Flow %
-2.06%
Top 10 Hldgs %
49.2%
Holding
43
New
2
Increased
13
Reduced
21
Closed
3

Top Buys

Rank Stock Value
1
CHYM
Chime Financial
CHYM
+$43.2M
2
BIIB icon
Biogen
BIIB
+$29.4M
3
FISV
Fiserv Inc
FISV
+$21.7M
4
NCLH icon
Norwegian Cruise Line
NCLH
+$15.7M
5
CROX icon
Crocs
CROX
+$14.2M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$63.4M
2
PGEN icon
Precigen
PGEN
+$30.1M
3
SOFI icon
SoFi Technologies
SOFI
+$29.4M
4
EXPE icon
Expedia Group
EXPE
+$19.1M
5
ANGI icon
Angi Inc
ANGI
+$13M

Sector Composition

Rank Sector Weight
1 Healthcare 24.15%
2 Consumer Discretionary 20.57%
3 Communication Services 15.3%
4 Financials 13.23%
5 Industrials 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$3.99T
$182M 7.03%
581,637
-31,696
-5% -$9.06M
C icon
2
Citigroup
C
$223B
$151M 5.82%
1,291,794
-18,613
-1% -$1.93M
AMZN icon
3
Amazon
AMZN
$2.49T
$130M 5.01%
562,559
+583
+0.1% +$133K
RPRX icon
4
Royalty Pharma
RPRX
$26B
$129M 4.97%
3,333,675
+215,825
+7% +$8.23M
QXO
5
QXO Inc
QXO
$14.7B
$125M 4.82%
6,468,854
-68,173
-1% -$1.31M
UNH icon
6
UnitedHealth
UNH
$379B
$122M 4.69%
368,293
-3,070
-0.8% -$1.04M
NVDA icon
7
NVIDIA
NVDA
$4.76T
$119M 4.6%
638,814
+6,130
+1% +$1.14M
NCLH icon
8
Norwegian Cruise Line
NCLH
$9.2B
$118M 4.57%
5,308,128
+743,257
+16% +$15.7M
BIIB icon
9
Biogen
BIIB
$29.5B
$101M 3.92%
576,352
+179,703
+45% +$29.4M
CVS icon
10
CVS Health
CVS
$137B
$97.7M 3.77%
1,231,416
-8,478
-0.7% -$668K
META icon
11
Meta Platforms (Facebook)
META
$1.51T
$94.5M 3.65%
143,094
-906
-0.6% -$605K
PPLI
12
People Inc
PPLI
$3.15B
$92.8M 3.58%
2,374,050
+265,805
+13% +$9.31M
ET icon
13
Energy Transfer Partners
ET
$68.5B
$86.9M 3.36%
5,272,875
+384,737
+8% +$6.4M
PGEN icon
14
Precigen
PGEN
$1.93B
$78.1M 3.01%
18,673,466
-7,787,382
-29% -$30.1M
ILMN icon
15
Illumina
ILMN
$28.7B
$75.5M 2.91%
575,768
-5,591
-1% -$656K
UAL icon
16
United Airlines
UAL
$39.1B
$73.1M 2.82%
654,121
-12,394
-2% -$1.25M
SDRL icon
17
Seadrill
SDRL
$2.69B
$71.1M 2.74%
2,053,797
-176,139
-8% -$5.49M
CROX icon
18
Crocs
CROX
$6.69B
$64.9M 2.5%
758,797
+170,003
+29% +$14.2M
GM icon
19
General Motors
GM
$78.7B
$62.8M 2.42%
771,647
-168,950
-18% -$11.9M
FBTC icon
20
Fidelity Wise Origin Bitcoin Fund
FBTC
$12.1B
$59.6M 2.3%
781,695
+161,943
+26% +$14.1M
OMF icon
21
OneMain Financial
OMF
$7.08B
$55.7M 2.15%
824,942
-111,971
-12% -$6.81M
MAT icon
22
Mattel
MAT
$4.3B
$55.4M 2.14%
2,794,343
+695,081
+33% +$13.4M
UBS icon
23
UBS Group
UBS
$172B
$55M 2.12%
1,187,326
-313,523
-21% -$12.7M
CHYM
24
Chime Financial
CHYM
$8.33B
$51.2M 1.98%
+2,035,112
New +$43.2M
EXPE icon
25
Expedia Group
EXPE
$33.4B
$49.9M 1.93%
176,282
-77,195
-30% -$19.1M
1
2

Similar funds

CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 14.19% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.73B AUM 28.24% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return
CC
Cartenna Capital Stamford, Connecticut $2.74B AUM 44.46% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return

Patient Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Patient Capital Management held 43 positions worth $2.59B, up 3.7% from $2.5B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Patient Capital Management's Q4 2025 filing shows 2 new, 13 increased, 21 reduced and 3 closed positions. Its largest new stake was Chime Financial: 2,035,112 shares worth $51.2M. The largest sale was Alibaba, an estimated $63.4M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Patient Capital Management's largest Q4 2025 buy was Chime Financial: 2,035,112 shares worth $51.2M.
  • Patient Capital Management added most to Biogen in Q4 2025, an estimated $29.4M increase.
  • Patient Capital Management's biggest Q4 2025 reduction was Alibaba, cutting an estimated $63.4M.
  • Patient Capital Management fully exited Angi Inc in Q4 2025, selling an estimated $13M.
  • Patient Capital Management's ten largest holdings make up 49% of its $2.59B portfolio in Q4 2025.
  • Patient Capital Management opened 2 new positions and closed 3 in Q4 2025.
  • Patient Capital Management's portfolio value rose 3.7% quarter-over-quarter to $2.59B.

Based on Patient Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.